Table 2.
LVSD at 30 days N = 41 | Non-LVSD at 30 daysN = 37 | p value | |
---|---|---|---|
Traditional parameters | |||
LVEF, % | 39.7 ± 7.1 | 57.3 ± 4.9 | <0.01 |
EDV, ml | 154.6 ± 34.2 | 136.1 ± 33.5 | 0.02 |
ESV, ml | 93.8 ± 25.7 | 59.1 ± 18.4 | <0.01 |
SV, ml | 60.9 ± 16.3 | 77.5 ± 18.2 | <0.01 |
HR, bpm | 68.6 ± 11.5 | 61.4 ± 11.5 | <0.01 |
CO, L | 4.14 ± 1.23 | 4.74 ± 1.13 | 0.03 |
Infarct size, % LV mass | 20.6 ± 10.0 | 7.4 ± 6.1 | <0.01 |
MVO presence | 22 (53.7) | 18 (48.6) | 0.66 |
MVO, %LV mass | 0.7 ± 0.9 | 0.6 ± 0.8 | 0.72 |
Left ventricular strain | |||
GRS, % | 17.4 ± 4.1 | 26.4 ± 5.2 | <0.01 |
GCS, % | −11.7 ± 2.6 | −16.2 ± 2.1 | <0.01 |
GLS, % | −9.9 ± 2.3 | −12.4 ± 2.2 | <0.01 |
Continuous variables are presented as mean ± SD. CMR indicates cardiovascular magnetic resonance imaging; CO, cardiac output; ESV, end-systole volume; EDV, end-diastole volume; GCS, global circumferential strain; GLS, global longitudinal strain; GRS, global radial strain; HR, heart rate; LVSD, left ventricular systolic dysfunction; LVEF, left ventricular ejection fraction; SV, stroke volume.